Cargando…

Androgen Receptor in Breast Cancer—Clinical and Preclinical Research Insights

The Androgen Receptor (AR) is emerging as an important factor in the pathogenesis of breast cancer (BC), which is the most common malignancy among females worldwide. The concordance of more than 70% of AR expression in primary and metastatic breast tumors implies that AR may be a new marker and a po...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anestis, Aristomenis, Zoi, Ilianna, Papavassiliou, Athanasios G., Karamouzis, Michalis V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7024330/ https://www.ncbi.nlm.nih.gov/pubmed/31952272 http://dx.doi.org/10.3390/molecules25020358

Ejemplares similares

Combining RANK/RANKL and ERBB-2 targeting as a novel strategy in ERBB-2-positive breast carcinomas
por: Zoi, Ilianna, et al.
Publicado: (2019)

The Molecular Basis of Retinoids’ Use in Breast Cancer Chemoprevention
por: Karamouzis, Michalis V., et al.
Publicado: (2007)

The Role of the RANKL/RANK Axis in the Prevention and Treatment of Breast Cancer with Immune Checkpoint Inhibitors and Anti-RANKL
por: Simatou, Aristofania, et al.
Publicado: (2020)

Pancreatic Cancer and Cachexia—Metabolic Mechanisms and Novel Insights
por: Poulia, Kalliopi Anna, et al.
Publicado: (2020)

HER-3 targeting alters the dimerization pattern of ErbB protein family members in breast carcinomas
por: Karamouzis, Michalis V., et al.
Publicado: (2015)

The role of autophagy in the treatment of BRAF mutant colorectal carcinomas differs based on microsatellite instability status
por: Koustas, Evangelos, et al.
Publicado: (2018)

Superior efficacy of the antifungal agent ciclopirox olamine over gemcitabine in pancreatic cancer models
por: Mihailidou, Chrysovalantou, et al.
Publicado: (2017)

The Interplay of Autophagy and Tumor Microenvironment in Colorectal Cancer—Ways of Enhancing Immunotherapy Action
por: Koustas, Evangelos, et al.
Publicado: (2019)

Inhibition of c‐MET increases the antitumour activity of PARP inhibitors in gastric cancer models
por: Koustas, Evangelos, et al.
Publicado: (2020)

The Resistance Mechanisms of Checkpoint Inhibitors in Solid Tumors
por: Koustas, Evangelos, et al.
Publicado: (2020)

Are cystic fibrosis mutation carriers a potentially highly vulnerable group to COVID‐19?
por: Sarantis, Panagiotis, et al.
Publicado: (2020)

Pancreatic ductal adenocarcinoma: Treatment hurdles, tumor microenvironment and immunotherapy
por: Sarantis, Panagiotis, et al.
Publicado: (2020)

Immune Microenvironment and Immunotherapeutic Management in Virus-Associated Digestive System Tumors
por: Sarantis, Panagiotis, et al.
Publicado: (2022)

Role of autophagy in cholangiocarcinoma: An autophagy-based treatment strategy
por: Koustas, Evangelos, et al.
Publicado: (2021)

Polycystin‐1 affects cancer cell behaviour and interacts with mTOR and Jak signalling pathways in cancer cell lines
por: Papavassiliou, Kostas A., et al.
Publicado: (2019)

Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide
por: Cochrane, Dawn R, et al.
Publicado: (2014)

Mechanisms of the Antitumor Activity of Low Molecular Weight Heparins in Pancreatic Adenocarcinomas
por: Bokas, Alexandros, et al.
Publicado: (2020)

Polycystin‐1 and hydrostatic pressure are implicated in glioblastoma pathogenesis in vitro
por: Zoi, Ilianna, et al.
Publicado: (2022)

Upgraded role of autophagy in colorectal carcinomas
por: Koustas, Evangelos, et al.
Publicado: (2018)

Gastrointestinal Stromal Tumors (GISTs): Novel Therapeutic Strategies with Immunotherapy and Small Molecules
por: Vallilas, Christos, et al.
Publicado: (2021)

The glucocorticoid receptor signalling in breast cancer
por: Moutsatsou, Paraskevi, et al.
Publicado: (2008)

Selective androgen receptor modulators in preclinical and clinical development
por: Narayanan, Ramesh, et al.
Publicado: (2008)

EGF-R is Expressed and AP-1 and NF-κ:B Are Activated in Stromal Myofibroblasts Surrounding Colon Adenocarcinomas Paralleling Expression of COX-2 and VEGF
por: Konstantinopoulos, Panagiotis A., et al.
Publicado: (2007)

Polycystin‐1 modulates RUNX2 activation and osteocalcin gene expression via ERK signalling in a human craniosynostosis cell model
por: Katsianou, Maira, et al.
Publicado: (2021)

Immunotherapy as a Therapeutic Strategy for Gastrointestinal Cancer—Current Treatment Options and Future Perspectives
por: Koustas, Evangelos, et al.
Publicado: (2022)

Response: Effects of physical activity on depressive symptoms during breast cancer survivorship: a meta-analysis of randomised control trials
por: Patsou, Efrossini D, et al.
Publicado: (2018)

The Implication of Autophagy in Gastric Cancer Progression
por: Koustas, Evangelos, et al.
Publicado: (2021)

Implication of gut microbiome in immunotherapy for colorectal cancer
por: Koustas, Evangelos, et al.
Publicado: (2022)

Combinatorial Treatment of Tinzaparin and Chemotherapy Can Induce a Significant Antitumor Effect in Pancreatic Cancer
por: Sarantis, Panagiotis, et al.
Publicado: (2021)

Survival Outcomes Following Combination of First-Line Platinum-Based Chemotherapy with S-1 in Patients with Advanced Gastric Cancer
por: Koumarianou, Anna, et al.
Publicado: (2020)

Autophagy-related Proteins as a Prognostic Factor of Patients With Colorectal Cancer
por: Koustas, Evangelos, et al.
Publicado: (2019)

Type 1 Nuclear Receptor Activity in Breast Cancer: Translating Preclinical Insights to the Clinic
por: Kumar, Sanjeev, et al.
Publicado: (2021)

The Androgen Receptor in Breast Cancer
por: Giovannelli, Pia, et al.
Publicado: (2018)

Activity of preclinical and phase I clinical trial of a novel androgen receptor antagonist GT0918 in metastatic breast cancer
por: Li, Huiping, et al.
Publicado: (2021)

Androgen receptor in breast cancer and its clinical implication
por: Hackbart, Hannah, et al.
Publicado: (2023)

Compartmentalisation of EGFR signalling might potentiate the optimal use of EGFR tyrosine kinase inhibitors in cancer therapeutics
por: Karamouzis, M V, et al.
Publicado: (2007)

Expression of androgen receptor splice variants in clinical breast cancers
por: Hickey, Theresa E., et al.
Publicado: (2015)

The role of androgens and polymorphisms in the androgen receptor in the epidemiology of breast cancer
por: Lillie, Elizabeth O, et al.
Publicado: (2003)

Physical activity and sociodemographic variables related to global health, quality of life, and psychological factors in breast cancer survivors
por: Patsou, Efrossini D, et al.
Publicado: (2018)

Editorial: The Androgen Receptor in Breast Cancer
por: Tesei, Anna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4o62ubjhg5m2nat593c9v5obtc